C57BL/6JGpt-Tdrd3em9Cd3747/Gpt

Mouse Model: Tdrd3-KO
Strain Number: T027481

Knockout (KO)

  • Product Type:
  • Quantity: - +
  • Sex:
  • Age:
  • Genotype:

GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library

With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.

BASIC INFORMATION
Strain Name: C57BL/6JGpt-Tdrd3em9Cd3747/Gpt
Strain Number: T027481
Official Symbol: Tdrd3
Strain Strategy: T027481.Tdrd3 Cas9-KO Strategy-EN.pdf
Official Full Name: tudor domain containing 3
Also Known As: 4732418C03Rik,6720468N18
NCBI Number: 219249
MGI Number: 2444023
Chromosome: 14
Deletion (size): -3747bp
Research Areas: immune system,Physiological system,Cell biology,Molecular biology,cellular,hematopoietic system,Golgi apparatus,cell nucleus,RNA binding protein
Strain Background: [N000013] C57BL/6JGpt
Modification Type: Knockout (KO)
Genotyping Protocols: T027481.Tdrd3 Genotyping Protocol(KO).pdf
Inventory Status: Cryopreserved
Sale Status: IF (Available for Distribution)
Health Status: Specific pathogen free (SPF)
Health Report: Please log in to view
Gene Family: Tudor domain containing

Extend the Value of Your Mouse Models with Integrated Preclinical Services

GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.